Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

PubWeight™: 10.13‹?› | Rank: Top 0.1%

🔗 View Article (PMID 32105632)

Published in Lancet Respir Med on February 24, 2020

Authors

Xiaobo Yang1, Yuan Yu2, Jiqian Xu2, Huaqing Shu2, Jia'an Xia3, Hong Liu1, Yongran Wu2, Lu Zhang4, Zhui Yu5, Minghao Fang6, Ting Yu3, Yaxin Wang2, Shangwen Pan2, Xiaojing Zou2, Shiying Yuan2, You Shang7

Author Affiliations

1: Department of Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Anesthesiology and Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Jin Yin-tan Hospital, Wuhan, China.
2: Department of Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Anesthesiology and Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
3: Jin Yin-tan Hospital, Wuhan, China.
4: Department of Critical Care Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Hubei, China.
5: Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
6: Union Hospital, and Department of Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
7: Department of Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Anesthesiology and Critical Care Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Jin Yin-tan Hospital, Wuhan, China. Electronic address: you_shang@yahoo.com.

Associated clinical trials:

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (NOSARSCOVID) | NCT04290871

Outcomes and Prognostic Factors in COVID-19 (COVIP) | NCT04321265

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection (GARM-COVID19) | NCT04326036

Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia (TOSCA) | NCT04332913

Hemodynamic Characteristics of Patients With SARS-CoV-2 (PiCCOVID) | NCT04337983

Pyridostigmine in Severe SARS-CoV-2 Infection (PISCO) | NCT04343963

Asymptomatic COVID-19 Infection Among Healthcare Workers | NCT04354792

Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS (RuXoCoil) | NCT04359290

COVID-19 Patient Positioning Pragmatic Trial | NCT04359797

Tocilizumab Treatment in Patients With COVID-19 | NCT04363853

The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients (SIDIACO) | NCT04365517

The Prone Position in Covid-19 Affected Patients (PRON-COVID) | NCT04365959

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs (ACICOVID) | NCT04373759

Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); | NCT04375709

Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 (CLUSCO) | NCT04379544

Rehabilitation for People With COVID-19 in ICU (COVID_REHAB) | NCT04381338

Sitagliptin Treatment in Diabetic COVID-19 Positive Patients (SIDIACO-RETRO') | NCT04382794

Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection. (PAIN-COVID) | NCT04394169

Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury (TAC-COVID19) | NCT04395482

Evaluating Clinical Parameters of COVID-19 in Pregnancy (COpregVID) | NCT04470583

A Survey to Assess Effects of Covid-19 on Cardiovascular Patients | NCT04508920

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection | NCT04513158